Carole Nuechterlein

Ms. Carole L. Nuechterlein serves as a Head at Roche Venture Fund.

Ms. Nuechterlein served as a Senior Vice President at SangStat since 2001. She joined the SangStat in October 1998 as Vice President & General Counsel.

She served at Roche Bioscience as Director of Legal Affairs. Ms. Nuechterlein also worked at Syntex Corporation prior to its acquisition by Roche Holding Ltd. in 1994. As Director of Legal Affairs, Ms. Nuechterlein specialized in transactional work, representing Roche in several divestitures of Syntex assets and in the negotiation of a number of research collaboration and licensing agreements.

Prior to that, she was in the San Francisco office of Skadden Arps Slate Meagher & Flom, specializing in mergers and acquisitions. She served as a Director of Alios Biopharma, Inc.

Ms. Nuechterlein holds her undergraduate degree from Valparaiso University (with honors) and her J.D. from the University of Michigan (with honors).

Carole Nuechterlein is the Head of Roche Venture Fund at Roche Venture Fund, based in Switzerland, Europe. With a background in Venture Capital, Carole Nuechterlein has a rich history of leadership and innovation. Carole Nuechterlein studied Undergraduate unknown @ Valparaiso University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.